|
1
|
Zohrap N, Saatci Ö, Ozes B, Coban I, Atay
HM, Battaloglu E, Şahin Ö and Bugra K: SIK2 attenuates
proliferation and survival of breast cancer cells with simultaneous
perturbation of MAPK and PI3K/Akt pathways. Oncotarget.
9:21876–21892. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang Y, Liu J, Ying X, Lin PC and Zhou BP:
Twist-mediated epithelial-mesenchymal transition promotes breast
tumor cell invasion via inhibition of hippo pathway. Sci Rep.
6(24606)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cancer Genome Atlas Network. Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
Cancer in China. Lancet Oncol. 15:e279–e289. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li CL, Yang D, Cao X, Wang F, Hong DY,
Wang J, Shen XC and Chen Y: Fibronectin induces
epithelial-mesenchymal transition in human breast cancer MCF-7
cells via activation of calpain. Oncol Lett. 13:3889–3895.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Al Moustafa AE, Achkhar A and Yasmeen A:
EGF-receptor signaling and epithelial-mesenchymal transition in
human carcinomas. Front Biosci (Schol Ed). 4:671–684.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lupia A, Peppicelli S, Witort E, Bianchini
F, Carloni V, Pimpinelli N, Urso C, Borgognoni L, Capaccioli S,
Calorini L and Lulli M: CD63 tetraspanin is a negative driver of
epithelial-to-mesenchymal transition in human melanoma cells. J
Invest Dermatol. 134:2947–2956. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jeong H, Ryu YJ, An J, Lee Y and Kim A:
Epithelial-mesenchymal transition in breast cancer correlates with
high histological grade and triple-negative phenotype.
Histopathology. 60:E87–E95. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yang D, Ma M, Zhou W, Yang B and Xiao C:
Inhibition of miR-32 activity promoted EMT induced by PM2.5
exposure through the modulation of the Smad1-mediated signaling
pathways in lung cancer cells. Chemosphere. 184:289–298.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Na Y, Kaul SC, Ryu J, Lee JS, Ahn HM, Kaul
Z, Kalra RS, Li L, Widodo N, Yun CO and Wadhwa R: Stress chaperone
mortalin contributes to epithelial-mesenchymal transition and
cancer metastasis. Cancer Res. 76:2754–2765. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hujie G, Zhou SH, Zhang H, Qu J, Xiong XW,
Hujie O, Liao CG and Yang SE: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in
hepatocellular carcinoma. Cancer Cell Int. 18(10)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li C, Jiang Y, Miao R, Qu K, Zhang J and
Liu C: MicroRNA-1271 functions as a metastasis and
epithelial-mesenchymal transition inhibitor in human HCC by
targeting the PTP4A1/c-Src axis. Int J Oncol. 52:536–546.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Wang Z, Sha HH and Li HJ: Functions and
mechanisms of miR-186 in human cancer. Biomed Pharmacother.
119(109428)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Iacona JR and Lutz CS: miR-146a-5p:
Expression, regulation, and functions in cancer. Wiley Interdiscip
Rev RNA. 10(e1533)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Chernyy V, Pustylnyak V, Kozlov V and
Gulyaeva L: Increased expression of miR-155 and miR-222 is
associated with lymph node positive status. J Cancer. 9:135–140.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bašová P, Pešta M, Sochor M and Stopka T:
Prediction potential of serum miR-155 and miR-24 for relapsing
early breast cancer. Int J Mol Sci. 18(E2116)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wei CY, Tan QX, Zhu X, Qin QH, Zhu FB, Mo
QG and Yang WP: Expression of CDKN1A/p21 and TGFBR2 in breast
cancer and their prognostic significance. Int J Clin Exp Pathol.
8:14619–14629. 2015.PubMed/NCBI
|
|
22
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261.
2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li X, Nadauld L, Ootani A, Corney DC, Pai
RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CWM, et al:
Oncogenic transformation of diverse gastrointestinal tissues in
primary organoid culture. Nat Med. 20:769–777. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Fricke F, Lee J, Michalak M, Warnken U,
Hausser I, Suarez-Carmona M, Halama N, Schnölzer M, Kopitz J and
Gebert J: TGFBR2-dependent alterations of exosomal cargo and
functions in DNA mismatch repair-deficient HCT116 colorectal cancer
cells. Cell Commun Signal. 15(14)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gao H, Li P, Hei Y, Li S, Wang J, Lv X and
Zhang J: Long Non-coding RNA-ZNF281 promotes cancer cell migration
and invasion in gastric cancer via downregulation of microRNA-124.
Oncol Lett. 19:1849–1855. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang J, Zhao B and Jin F: The assessment
of 8th edition AJCC prognostic staging system and a simplified
staging system for breast cancer: The analytic results from the
SEER database. Breast J. 25:838–847. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kang W, Tong JH, Lung RW, Dong Y, Zhao J,
Liang Q, Zhang L, Pan Y, Yang W, Pang JC, et al: Targeting of YAP1
by microRNA-15a and microRNA-16-1 exerts tumor suppressor function
in gastric adenocarcinoma. Mol Cancer. 14(52)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu J, Wang Y, Shang L, Qi L and Song M:
Five common functional polymorphisms in microRNAs and
susceptibility to breast cancer: An updated meta-analysis. Genet
Test Mol Biomarkers. 22:350–358. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sandiford OA, Moore CA, Du J, Boulad M,
Gergues M, Eltouky H and Rameshwar P: Human Aging and Cancer: Role
of miRNA in Tumor Microenvironment. Adv Exp Med Biol. 1056:137–152.
2018.PubMed/NCBI View Article : Google Scholar
|
